A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Mauduit, Marjorie ^a,b,c   Grüner, Anne Charlotte ^a,b,c   Tewari, Rita ^d,e   Depinay, Nadya ^b,c   Kayibanda, Michèle ^b,c   Chavatte, Jean Marc ^f   Franetich, Jean François ^c,g   Crisanti, Andrea ^d   Mazier, Dominique ^c,g,h   Snounou, Georges ^c,f,g   Rénia, Laurent ^a,b,c  

^a AGENCY FOR SCIENCE   (Singapore)

^b INSTITUT COCHIN   (France)

^c INSERM   (France)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^g SORBONNE UNIVERSITÉ   (France)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCUMSPOROZOITE PROTEIN; MALARIA VACCINE; CIRCUMSPOROZOITE PROTEIN, PROTOZOAN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARASITE ANTIGEN; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS REACTION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; IRRADIATION; MALARIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; SPOROZOITE; VACCINE PRODUCTION; ANIMAL; BAGG ALBINO MOUSE; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; RODENTIA;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; FEMALE; IMMUNE SYSTEM; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; PLASMODIUM BERGHEI; PLASMODIUM YOELII; PROTOZOAN PROTEINS; SPOROZOITES;

EID: 70450195853     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007717     Document Type: Article

References (45)

1. Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, et al. (2002) Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 185: 1155-1164.
2. Nussenzweig RS, Vanderberg JP, Spitalny GL, Rivera-Ortiz C, Orton CG, et al. (1972) Sporozoite induced immunity in mammalian malaria. A review. Am J Trop Med Hyg 21: 722-728.
3. Druilhe P, Renia L, Fidock DA (1998) Immunity to Liver stages. In: Sherman IW, ed. Malaria: Parasite Biology, Pathogenesis, and Protection. Washington, D.C.: ASM Press. pp 513-543.
4. Zavala F, Tam JP, Masuda A (1986) Synthetic peptides as antigens for the detection of humoral immunity to Plasmodium falciparum sporozoites. J Immunol Methods 93: 55-61.
5. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, et al. (1989) Cloned cytotoxic T cells recognize an epitope on the circumsporozoite protein and protect against malaria. Nature 341: 323-325.
6. Rodrigues MM, Cordey AS, Arreaza G, Corradin G, Romero P, et al. (1991) CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int Immunol 3: 579-585.
7. + T cell clones against Plasmodium yoelii liver stages. J Immunol 150: 1471-1478.
8. Kumar KA, Sano G, Boscardin S, Nussenzweig RS, Nussenzweig MC, et al. (2006) The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444: 937-940.
9. Hoffman SL (2006) Malaria: a protective paradox. Nature 444: 824-827.
10. Gruner AC, Mauduit M, Tewari R, Romero JF, Depinay N, et al. (2007) Sterile Protection against Malaria Is Independent of Immune Responses to the Circumsporozoite Protein. PLoS ONE 2: e1371.
11. Sedegah M, Weiss WR, Hoffman SL (2007) Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoites. Parasite Immunol 29: 559-565.
12. Weiss WR, Berzofsky JA, Houghten RA, Sedegah M, Hollingdale MR, et al. (1992) A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei. J Immunol 149: 2103-2109.
13. Tewari R, Rathore D, Crisanti A (2005) Motility and infectivity of Plasmodium berghei sporozoites expressing avian Plasmodium gallinaceum circumsporozoite protein. Cell Microbiol 7: 699-707.
14. Nardin EH, Nussenzweig V, Nussenzweig RS, Collins WE, Harinasuta T, et al. (1982) Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and P. vivax. J Exp Med 156: 20-30.
15. Marussig M, Renia L, Motard A, Miltgen F, Petour P, et al. (1997) Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection. Int Immunol 9: 1817-1824.
16. Migliorini P, Betschart B, Corradin G (1993) Malaria vaccine: immunization of mice with a synthetic T cell helper epitope alone leads to protective immunity. Eur J Immunol 23: 582-585.
17. Sedegah M, Hedstrom RC, Hobart P, Hoffman SL (1994) Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc Natl Acad Sci U S A 91: 9866-9870.
18. Zavala F, Tam JP, Barr PJ, Romero P, Ley V, Nussenzweig RS, Nussenzweig V (1987) Synthetic peptide vaccine confers protection against murine malaria. J Exp Med 166: 1591-1596.
19. Kester KE, McKinney DA, Tornieporth N, Ockenhouse CF, Heppner DG, et al. (2001) Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria. J Infect Dis 183: 640-647.
20. Kester KE, Cummings JF, Ockenhouse CF, Nielsen R, Hall BT, et al. (2008) Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naive adults at the Walter Reed Army Institute of Research. Vaccine 26: 2191-2202.
21. Stoute JA, Slaoui M, Heppner DG, Jr., Momin P, Kester KE, et al. (1997) A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. N Engl J Med 336: 86-91.
22. Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, et al. (2004) Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 364: 1411-1420.
23. Bojang KA, Milligan PJM, Pinder M, Vigneron L, Alloueche A, et al. (2001) Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 358: 1927-1934.
24. Snounou G, Gruner AC, Muller-Graf CD, Mazier D, Renia L (2005) The Plasmodium sporozoite survives RTS,S vaccination. Trends Parasitol 21: 456-461.
25. Abdulla S, Oberholzer R, Juma O, Kubhoja S, Machera F, et al. (2008) Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N Engl J Med 359: 2533-2544.
26. Bejon PA, Lusingu J, Olotu A, Leach A, Lievens M, et al. (2008) Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med 359: 2521-2532.
27. Mikolajczak SA, Aly AS, Kappe SH (2007) Preerythrocytic malaria vaccine development. Curr Opin Infect Dis 20: 461-466.
28. Clyde DF, McCarthy VC, Miller RM, Hornick RB (1973) Specificity of protection of man immunized against sporozoite- induced falciparum malaria. Am J Med Sci 266: 398-403.
29. Belnoue E, Costa FTM, Frankenberg T, Vigario AM, Voza T, et al. (2004) Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol 172: 2487-2495.
30. Belnoue E, Voza T, Costa FTM, Gruner AC, Mauduit M, et al. (2008) Vaccination with Live Plasmodium yoelii Blood Stage Parasites under Chloroquine Cover Induces Cross-Stage Immunity against Malaria Liver Stage. J Immunol 181: 8552-8558.
31. Mueller AK, Labaied M, Kappe SH, Matuschewski K (2005) Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433: 164-167.
32. Renia L, Gruner AC, Mauduit M, Snounou G (2006) Vaccination against malaria with live parasites. Expert Rev Vaccines 5: 473-481.
33. van Dijk MR, Douradinha B, Franke-Fayard B, Heussler VT, van Dooren MW, et al. (2005) Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc Natl Acad Sci US A 102: 12194-12199.
34. Luke TC, Hoffman SL (2003) Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. J Exp Biol 206: 3803-3808.
35. Janse CJ, Mons B, Rouwenhorst RJ, van der Klooster PF, Overdulve JP, et al. (1985) In vitro formation of ookinetes and functional maturity of Plasmodium berghei gametocytes. Parasitology 91: 19-29.
36. Franke-Fayard B, Trueman H, Ramesar J, Mendoza J, van der Keur M, et al. (2004) A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol Biochem Parasitol 137: 23-33.
37. Hulier E, Petour P, Snounou G, Nivez MP, Miltgen F, et al. (1996) A method for the quantitative assessment of malaria parasite development in organs of the mammalian host. Mol Biochem Parasitol 77: 127-135.
38. Preiser PR, Khan SM, Costa FTM, Jarra W, Belnoue E, et al. (2002) Stage-specific transcription of distinct repertoires of a multigene family during Plasmodium life cycle. Science 295: 342-345.
39. Bruna-Romero O, Hafalla JC, Gonzalez-Aseguinolaza G, Sano G, Tsuji M, et al. (2001) Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR. Int J Parasitol 31: 1499-1502.
40. Grillot DA, Michel M, Muller I, Tougne C, Renia L, et al. (1990) Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii. Eur J Immunol 20: 1215-1222.
41. Weiss WR, Mellouk S, Houghten RA, Sedegah M, Kumar S, et al. (1990) Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J Exp Med 171: 763-773.
42. Lopez JA, Renggli J, Eberl G, Corradin G, Roggero MA, et al. (1996) Immunogenicity of synthetic peptides corresponding to the nonrepeat regions of the Plasmodium falciparum circumsporozoite protein. In: Vaccines 96, Cold Spring Harbor Laboratory Press. pp 255-260.
43. Renia L, Miltgen F, Charoenvit Y, Ponnudurai T, Verhave JP, et al. (1988) Malaria sporozoite penetration: a new approach by double staining. J Immunol Methods 112: 201-205.
44. Silvie O, Greco C, Franetich JF, Dubart-Kupperschmitt A, Hannoun L, et al. (2006) Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species. Cell Microbiol 8: 1134-1146.
45. Renia L, Mattei DM, Goma J, Pied S, Dubois P, et al. (1990) A malaria heat shock like protein epitope expressed on the infected hepatocyte surface is the target of antibody-dependent cell-mediated cytotoxic mechanisms by non-parechymal liver cells. Eur J Immunol 20: 1445-1449.